๋ฒ ๋ผํŒŒ๋ฐ€ / Verapamil

์ •์˜

Verapamil์€ ์นผ์Š˜์ฑ„๋„์ฐจ๋‹จ์ œ๋กœ, ํŠน์ • ๋นˆ๋งฅ ์ƒํ™ฉ์—์„œ IV ํˆฌ์—ฌ ์‹œ ๋น ๋ฅธ ์ž„์ƒ ํšจ๊ณผ๋ฅผ ๊ธฐ๋Œ€ํ•  ์ˆ˜ ์žˆ๋‹ค.

์ž„์ƒ ํ•ต์‹ฌ

Immediate-release PO verapamil์€ ํ˜ˆ์ค‘ peak๊ฐ€ ๋Œ€๋žต 1โ€“2์‹œ๊ฐ„ ํ›„๋ผ ๊ธ‰์„ฑ ๋นˆ๋งฅ termination ๋ชฉ์ ์—๋Š” ์ ํ•ฉํ•˜์ง€ ์•Š๋‹ค. Sustained/extended-release ์ œํ˜•์€ ๋” ๋Šฆ๊ณ  ์™„๋งŒํ•˜๊ฒŒ ์ƒ์Šนํ•œ๋‹ค. IV verapamil์€ bolus ํ›„ peak therapeutic effect๊ฐ€ ์•ฝ 3โ€“5๋ถ„์œผ๋กœ ๋น ๋ฅด๋‹ค. Verapamil-sensitive fascicular VT์—์„œ โ€œ๋ฐ˜์‘์„ ๋ณธ๋‹คโ€๋Š” ๋งฅ๋ฝ์€ ๋ณดํ†ต stable patient์—์„œ IV verapamil์ด๋‹ค.

์ง„๋‹จ

Verapamil ์‚ฌ์šฉ ์ „ rhythm์ด AF + WPW ์˜์‹ฌ irregular wide complex tachycardia์ธ์ง€ ๋ฐ˜๋“œ์‹œ ๊ตฌ๋ถ„ํ•ด์•ผ ํ•œ๋‹ค.

์น˜๋ฃŒ

Stable fascicular VT๊ฐ€ ์˜์‹ฌ๋  ๋•Œ IV verapamil ๋ฐ˜์‘์„ ๊ณ ๋ คํ•  ์ˆ˜ ์žˆ๋‹ค. AF + WPW ์˜์‹ฌ irregular WCT์—์„œ๋Š” verapamil์€ ๊ธˆ๊ธฐ๋‹ค. Unstable wide complex tachycardia์—์„œ๋Š” ์•ฝ๋ฌผ ๋ฐ˜์‘์„ ๊ธฐ๋‹ค๋ฆฌ์ง€ ๋ง๊ณ  ACLS์— ๋”ฐ๋ผ synchronized cardioversion์„ ์šฐ์„ ํ•œ๋‹ค.

์ถœ์ฒ˜

๐ŸŒฑ ์ถœ์ฒ˜ raw


๋ณธ ๋ฌธ์„œ๋Š” ํ•™์Šตยท์ฐธ๊ณ ์šฉ์ด๋ฉฐ ์‹ค์ œ ์ง„๋ฃŒ ๊ฒฐ์ •์€ ์ž„์ƒ์˜์˜ ํŒ๋‹จ์ž…๋‹ˆ๋‹ค.